Cost-effectiveness analysis of adebrelimab in combination with chemotherapy for first-line treatment of extensive-stage small cell lung cancer. Zheng Z, Zhu H, Fang L. PLoS One 2025;20:e0325171.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zheng Z, Zhu H, Fang L. Cost-effectiveness analysis of adebrelimab in combination with chemotherapy for first-line treatment of extensive-stage small cell lung cancer. PLoS One 2025;20:e0325171.
PMID: 40512778